Advertisement

Topics

EGEN, Inc. Company Profile

10:27 EDT 21st September 2017 | BioPortfolio

EGEN, Inc., is a privately held biopharmaceutical company located in Huntsville, Alabama and is focused on developing therapeutics for the treatment of human diseases via nucleic acid (DNA and RNAi) delivery. The Company has a significant intellectual property position in delivery systems, their novel compositions with nucleic acids and their therapeutic applications. EGEN's research pipeline includes products involving siRNA, shRNA and plasmid DNA for the treatment of various cancers and other diseases and has a number of collaborations with outside investigators, biotech organizations and universities on various projects in these areas.


News Articles [1 Associated News Articles listed on BioPortfolio]

EGEN, Inc. Collaborates With Nanotechnology Characterization Laboratory on Brain Cancer Therapy

HUNTSVILLE, Ala., Sept. 26, 2011 /PRNewswire/ -- EGEN, Inc. is collaborating with the National Cancer Institute's Nanotechnology Characterization Laboratory in Frederick, Md., to accelerate human clin...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

RATIONALE: Biological therapies, such as EGEN-001, may stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase II clinical trial is studying t...

Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the cells of the body. Because the genes are damaged, the body is unable to produce a group of protei...

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the body's cells. When genes are damaged, the body may be unable to produce a group of proteins, call...

Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy

The task consists in reach as much bubbles as they can, the bubbles appear on the screen of the computer and should be reached in 10 seconds. To accomplish that, three different devices wi...

Companies [3 Associated Companies listed on BioPortfolio]

EGEN, Inc.

EGEN, Inc., is a privately held biopharmaceutical company located in Huntsville, Alabama and is focused on developing therapeutics for the treatment of human diseases via nucleic acid (DNA and RNAi) d...

Expression Genetics, Inc.

Expression Genetics, Inc. (EGEN), is a privately held biopharmaceutical company specializing in nucleic acid (DNA and RNAi) delivery and therapeutics aimed at specific disease targets. The Company...

Expression Genetics, Inc

An Alabama-based specialty biopharmaceutical company developing safe and efficient polymeric delivery systems to be used to create products for treatment of human diseases. Our delivery vehicles, base...

More Information about "EGEN, Inc." on BioPortfolio

We have published hundreds of EGEN, Inc. news stories on BioPortfolio along with dozens of EGEN, Inc. Clinical Trials and PubMed Articles about EGEN, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EGEN, Inc. Companies in our database. You can also find out about relevant EGEN, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record